<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Investment Decision Report: HealthBridge AI Inc.</title>
    <style>
        
        * { box-sizing: border-box; margin: 0; padding: 0; }
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, sans-serif;
            line-height: 1.6;
            color: #1a1a1a;
            background: #f5f5f5;
        }
        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            box-shadow: 0 0 20px rgba(0,0,0,0.1);
        }
        .report-header {
            background: linear-gradient(135deg, #1e3a5f 0%, #2d5a87 100%);
            color: white;
            padding: 40px;
            text-align: center;
        }
        .report-header h1 { font-size: 28px; margin-bottom: 10px; }
        .report-meta { font-size: 14px; opacity: 0.9; }
        .toc {
            background: #f8f9fa;
            padding: 20px 40px;
            border-bottom: 1px solid #e0e0e0;
        }
        .toc h2 { font-size: 16px; margin-bottom: 10px; color: #666; }
        .toc ul { list-style: none; display: flex; flex-wrap: wrap; gap: 15px; }
        .toc a { color: #2d5a87; text-decoration: none; font-size: 14px; }
        .toc a:hover { text-decoration: underline; }
        main { padding: 40px; }
        section { margin-bottom: 40px; }
        section h2 {
            font-size: 22px;
            color: #1e3a5f;
            border-bottom: 2px solid #2d5a87;
            padding-bottom: 10px;
            margin-bottom: 20px;
        }
        section h3 {
            font-size: 18px;
            color: #333;
            margin: 20px 0 10px;
        }
        .decision-box {
            display: flex;
            align-items: center;
            gap: 20px;
            padding: 20px;
            border-radius: 8px;
            margin-bottom: 20px;
        }
        .decision-invest { background: #e8f5e9; border: 2px solid #4caf50; }
        .decision-pass { background: #ffebee; border: 2px solid #f44336; }
        .decision-defer { background: #fff8e1; border: 2px solid #ff9800; }
        .decision-badge {
            font-size: 24px;
            font-weight: bold;
            padding: 10px 20px;
            border-radius: 4px;
            color: white;
        }
        .decision-invest .decision-badge { background: #4caf50; }
        .decision-pass .decision-badge { background: #f44336; }
        .decision-defer .decision-badge { background: #ff9800; }
        .confidence-bar {
            flex: 1;
            background: #e0e0e0;
            height: 20px;
            border-radius: 10px;
            overflow: hidden;
        }
        .confidence-fill {
            height: 100%;
            background: linear-gradient(90deg, #2d5a87 0%, #4caf50 100%);
            transition: width 0.3s ease;
        }
        .key-points { display: grid; grid-template-columns: 1fr 1fr; gap: 20px; margin: 20px 0; }
        .key-points-box {
            padding: 15px;
            border-radius: 8px;
        }
        .strengths { background: #e8f5e9; border-left: 4px solid #4caf50; }
        .risks { background: #ffebee; border-left: 4px solid #f44336; }
        .key-points-box h4 { font-size: 14px; color: #666; margin-bottom: 10px; }
        .key-points-box ul { margin-left: 20px; }
        .key-points-box li { font-size: 14px; margin-bottom: 5px; }
        .evidence-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 14px;
            margin: 15px 0;
        }
        .evidence-table th, .evidence-table td {
            padding: 10px;
            text-align: left;
            border-bottom: 1px solid #e0e0e0;
        }
        .evidence-table th { background: #f5f5f5; font-weight: 600; }
        .polarity-supportive { color: #2e7d32; }
        .polarity-risk { color: #c62828; }
        .polarity-neutral { color: #666; }
        .stat-grid { display: grid; grid-template-columns: repeat(4, 1fr); gap: 15px; margin: 20px 0; }
        .stat-box {
            text-align: center;
            padding: 15px;
            background: #f8f9fa;
            border-radius: 8px;
        }
        .stat-value { font-size: 28px; font-weight: bold; color: #1e3a5f; }
        .stat-label { font-size: 12px; color: #666; margin-top: 5px; }
        .rule-eval {
            padding: 15px;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            margin-bottom: 10px;
        }
        .rule-header { display: flex; justify-content: space-between; align-items: center; }
        .rule-name { font-weight: 600; }
        .rule-result {
            padding: 4px 12px;
            border-radius: 4px;
            font-size: 12px;
            font-weight: 600;
        }
        .rule-pass { background: #e8f5e9; color: #2e7d32; }
        .rule-fail { background: #ffebee; color: #c62828; }
        .rule-partial { background: #fff8e1; color: #f57c00; }
        .sensitivity-item {
            padding: 15px;
            border-left: 4px solid #ff9800;
            background: #fff8e1;
            margin-bottom: 10px;
            border-radius: 0 8px 8px 0;
        }
        .sensitivity-header { font-weight: 600; margin-bottom: 5px; }
        .sensitivity-explanation { font-size: 14px; color: #666; }
        .uncertainty-meter {
            display: flex;
            gap: 20px;
            margin: 20px 0;
        }
        .uncertainty-item {
            flex: 1;
            text-align: center;
            padding: 20px;
            border-radius: 8px;
            background: #f8f9fa;
        }
        .uncertainty-label { font-size: 12px; color: #666; margin-bottom: 5px; }
        .uncertainty-value { font-size: 24px; font-weight: bold; color: #1e3a5f; }
        .data-gaps {
            background: #fff3e0;
            padding: 15px;
            border-radius: 8px;
            margin: 15px 0;
        }
        .data-gaps h4 { color: #e65100; margin-bottom: 10px; }
        .data-gaps ul { margin-left: 20px; }
        .recommendations {
            background: #e3f2fd;
            padding: 15px;
            border-radius: 8px;
            margin: 15px 0;
        }
        .recommendations h4 { color: #1565c0; margin-bottom: 10px; }
        .metadata-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 10px; }
        .metadata-item { font-size: 14px; padding: 8px 0; border-bottom: 1px solid #f0f0f0; }
        .metadata-label { color: #666; }
        .metadata-value { font-weight: 500; }
        .report-footer {
            background: #1e3a5f;
            color: white;
            padding: 30px 40px;
        }
        .disclaimer {
            background: rgba(255,255,255,0.1);
            padding: 15px;
            border-radius: 8px;
            font-size: 13px;
            margin-bottom: 15px;
        }
        .footer-meta { font-size: 12px; opacity: 0.8; text-align: center; }
        @media print {
            .container { box-shadow: none; }
            .toc { break-after: page; }
            section { break-inside: avoid; }
        }
        
    </style>
</head>
<body>
    <div class="container">
        <header class="report-header">
            <h1>Investment Decision Report: HealthBridge AI Inc.</h1>
            <div class="report-meta">
                Generated: 2026-01-12 20:23 UTC
                | Report ID: report_ff4e526bbf9b
            </div>
        </header>

        <nav class="toc">
            <h2>Contents</h2>
            <ul>
                <li><a href="#executive-summary">Executive Summary</a></li>
                <li><a href="#decision-logic">Inferred Decision Logic</a></li>
                <li><a href="#evidence-basis">Evidence Basis</a></li>
                <li><a href="#deal-evaluation">Deal Evaluation</a></li>
                <li><a href="#counterfactual-analysis">Counterfactual & Sensitivity Analysis</a></li>
                <li><a href="#uncertainty">Uncertainty & Limitations</a></li>
                <li><a href="#audit-metadata">Audit Metadata</a></li>
            </ul>
        </nav>

        <main>
            
        <section id="executive-summary">
            <h2>1. Executive Summary</h2>

            <div class="decision-box decision-defer">
                <span class="decision-badge">DEFER</span>
                <div style="flex: 1;">
                    <div style="font-size: 14px; color: #666; margin-bottom: 5px;">
                        Confidence: 50% (low)
                    </div>
                    <div class="confidence-bar">
                        <div class="confidence-fill" style="width: 50.0%;"></div>
                    </div>
                </div>
            </div>

            <p style="font-size: 18px; margin-bottom: 20px; font-weight: 500;">
                Recommend DEFER decision on HealthBridge AI Inc. pending additional due diligence (50% confidence).
            </p>

            <div class="key-points">
                <div class="key-points-box strengths">
                    <h4>Key Strengths</h4>
                    <ul>
                        <li>traction: pilot_clinics (3)</li><li>traction: physician_nps (72)</li><li>traction: diagnoses_assisted (15000)</li><li>team_quality: founder_background (MIT CS PhD, 8 years ML at Apple Health)</li><li>product_readiness: stage (production)</li>
                    </ul>
                </div>
                <div class="key-points-box risks">
                    <h4>Key Risks</h4>
                    <ul>
                        <li>execution_risk: domain_expertise_gap (No full-time clinical leadership; advisors part-time)</li><li>regulatory_risk: clearance_timeline (12-18 months estimated)</li><li>business_model: sales_cycle (6-9 months average)</li><li>differentiation: competitors (Nuance (Microsoft), Isabel Healthcare, Infermedica)</li><li>execution_risk: competitive_threat (Microsoft Nuance has 500x resources; unclear differentiation path)</li>
                    </ul>
                </div>
            </div>

            

            <div style="background: #f5f5f5; padding: 15px; border-radius: 8px; margin-top: 20px;">
                <p style="font-size: 14px; line-height: 1.7;">
                    The evidence is insufficient to make a definitive investment decision (50% confidence). DISCLAIMER: This is decision support only, not investment advice. Final investment decisions remain the responsibility of the investment committee.
                </p>
            </div>
        </section>
        
            
        <section id="decision-logic">
            <h2>2. Inferred Decision Logic</h2>

            <div class="stat-grid">
                <div class="stat-box">
                    <div class="stat-value">+5.82</div>
                    <div class="stat-label">Net Signal Score</div>
                </div>
                <div class="stat-box">
                    <div class="stat-value">0</div>
                    <div class="stat-label">Primary Factors</div>
                </div>
                <div class="stat-box">
                    <div class="stat-value">6</div>
                    <div class="stat-label">Rules Evaluated</div>
                </div>
                <div class="stat-box">
                    <div class="stat-value">4</div>
                    <div class="stat-label">Rules Passed</div>
                </div>
            </div>

            <h3>Decision Threshold</h3>
            <p style="font-size: 14px; color: #666; margin-bottom: 20px;">
                Net signal score (5.82) is in the uncertain zone. Neither clear invest nor pass criteria are met.
            </p>

            <h3>Rule Evaluations</h3>
            
            <div class="rule-eval">
                <div class="rule-header">
                    <span class="rule-name">Traction Assessment</span>
                    <span class="rule-result rule-pass">PASS</span>
                </div>
                <p style="font-size: 13px; color: #666; margin-top: 5px;">Evaluate revenue traction and growth metrics</p>
                <p style="font-size: 12px; color: #888; margin-top: 5px;">
                    Evidence: traction.arr, traction.pilot_clinics, traction.physician_nps
                </p>
            </div>
            
            <div class="rule-eval">
                <div class="rule-header">
                    <span class="rule-name">Team Assessment</span>
                    <span class="rule-result rule-pass">PASS</span>
                </div>
                <p style="font-size: 13px; color: #666; margin-top: 5px;">Assess founder and team quality</p>
                <p style="font-size: 12px; color: #888; margin-top: 5px;">
                    Evidence: team_quality.founder_background, team_composition.team_size, team_composition.clinical_advisors
                </p>
            </div>
            
            <div class="rule-eval">
                <div class="rule-header">
                    <span class="rule-name">Market Assessment</span>
                    <span class="rule-result rule-pass">PASS</span>
                </div>
                <p style="font-size: 13px; color: #666; margin-top: 5px;">Evaluate market opportunity and timing</p>
                <p style="font-size: 12px; color: #888; margin-top: 5px;">
                    Evidence: market_scope.tam, market_scope.market_timing
                </p>
            </div>
            
            <div class="rule-eval">
                <div class="rule-header">
                    <span class="rule-name">Business Model Assessment</span>
                    <span class="rule-result rule-partial">PARTIAL</span>
                </div>
                <p style="font-size: 13px; color: #666; margin-top: 5px;">Assess unit economics and business model viability</p>
                <p style="font-size: 12px; color: #888; margin-top: 5px;">
                    Evidence: business_model.revenue_model, business_model.sales_cycle, business_model.gross_margin
                </p>
            </div>
            
            <div class="rule-eval">
                <div class="rule-header">
                    <span class="rule-name">Risk Assessment</span>
                    <span class="rule-result rule-fail">FAIL</span>
                </div>
                <p style="font-size: 13px; color: #666; margin-top: 5px;">Identify and weigh execution and regulatory risks</p>
                <p style="font-size: 12px; color: #888; margin-top: 5px;">
                    Evidence: execution_risk.domain_expertise_gap, execution_risk.competitive_threat, regulatory_risk.fda_status
                </p>
            </div>
            
            <div class="rule-eval">
                <div class="rule-header">
                    <span class="rule-name">Technical Assessment</span>
                    <span class="rule-result rule-pass">PASS</span>
                </div>
                <p style="font-size: 13px; color: #666; margin-top: 5px;">Evaluate product readiness and technical moat</p>
                <p style="font-size: 12px; color: #888; margin-top: 5px;">
                    Evidence: product_readiness.stage, technical_moat.proprietary_data
                </p>
            </div>
            

            <h3>Decision Rationale</h3>
            <p style="font-size: 14px; background: #f5f5f5; padding: 15px; border-radius: 8px;">
                The decision to DEFER reflects insufficient evidence or high uncertainty (net signal: 5.82, 31 claims). Additional due diligence is recommended before making a final determination.
            </p>
        </section>
        
            
        <section id="evidence-basis">
            <h2>3. Evidence Basis</h2>

            <div class="stat-grid">
                <div class="stat-box">
                    <div class="stat-value">31</div>
                    <div class="stat-label">Total Claims</div>
                </div>
                <div class="stat-box">
                    <div class="stat-value" style="color: #2e7d32;">12</div>
                    <div class="stat-label">Supportive</div>
                </div>
                <div class="stat-box">
                    <div class="stat-value" style="color: #c62828;">5</div>
                    <div class="stat-label">Risk</div>
                </div>
                <div class="stat-box">
                    <div class="stat-value">82%</div>
                    <div class="stat-label">Avg Confidence</div>
                </div>
            </div>

            <h3>Supportive Evidence</h3>
            
            <table class="evidence-table">
                <thead>
                    <tr>
                        <th>Type</th>
                        <th>Field</th>
                        <th>Value</th>
                        <th>Confidence</th>
                        <th>Polarity</th>
                    </tr>
                </thead>
                <tbody>
                <tr>
                    <td>traction</td>
                    <td>pilot_clinics</td>
                    <td>3</td>
                    <td>90%</td>
                    <td class="polarity-supportive">supportive</td>
                </tr>
                
                <tr>
                    <td>traction</td>
                    <td>physician_nps</td>
                    <td>72</td>
                    <td>80%</td>
                    <td class="polarity-supportive">supportive</td>
                </tr>
                
                <tr>
                    <td>traction</td>
                    <td>diagnoses_assisted</td>
                    <td>15000</td>
                    <td>85%</td>
                    <td class="polarity-supportive">supportive</td>
                </tr>
                
                <tr>
                    <td>team_quality</td>
                    <td>founder_background</td>
                    <td>MIT CS PhD, 8 years ML at Apple Health</td>
                    <td>92%</td>
                    <td class="polarity-supportive">supportive</td>
                </tr>
                
                <tr>
                    <td>product_readiness</td>
                    <td>stage</td>
                    <td>production</td>
                    <td>90%</td>
                    <td class="polarity-supportive">supportive</td>
                </tr>
                
                <tr>
                    <td>technical_moat</td>
                    <td>proprietary_data</td>
                    <td>500K de-identified patient encounters from pilots</td>
                    <td>75%</td>
                    <td class="polarity-supportive">supportive</td>
                </tr>
                
                <tr>
                    <td>differentiation</td>
                    <td>accuracy</td>
                    <td>92% concordance with specialist diagnoses in pilot</td>
                    <td>70%</td>
                    <td class="polarity-supportive">supportive</td>
                </tr>
                
                <tr>
                    <td>market_scope</td>
                    <td>tam</td>
                    <td>12000000000</td>
                    <td>65%</td>
                    <td class="polarity-supportive">supportive</td>
                </tr>
                
                <tr>
                    <td>market_scope</td>
                    <td>market_timing</td>
                    <td>Post-COVID telehealth adoption accelerating AI int</td>
                    <td>75%</td>
                    <td class="polarity-supportive">supportive</td>
                </tr>
                
                <tr>
                    <td>regulatory_risk</td>
                    <td>hipaa_compliance</td>
                    <td>SOC 2 Type II certified, HIPAA BAAs in place</td>
                    <td>90%</td>
                    <td class="polarity-supportive">supportive</td>
                </tr>
                </tbody>
            </table>
            

            <h3>Risk Evidence</h3>
            
            <table class="evidence-table">
                <thead>
                    <tr>
                        <th>Type</th>
                        <th>Field</th>
                        <th>Value</th>
                        <th>Confidence</th>
                        <th>Polarity</th>
                    </tr>
                </thead>
                <tbody>
                <tr>
                    <td>execution_risk</td>
                    <td>domain_expertise_gap</td>
                    <td>No full-time clinical leadership; advisors part-ti</td>
                    <td>80%</td>
                    <td class="polarity-risk">risk</td>
                </tr>
                
                <tr>
                    <td>regulatory_risk</td>
                    <td>clearance_timeline</td>
                    <td>12-18 months estimated</td>
                    <td>60%</td>
                    <td class="polarity-risk">risk</td>
                </tr>
                
                <tr>
                    <td>business_model</td>
                    <td>sales_cycle</td>
                    <td>6-9 months average</td>
                    <td>75%</td>
                    <td class="polarity-risk">risk</td>
                </tr>
                
                <tr>
                    <td>differentiation</td>
                    <td>competitors</td>
                    <td>Nuance (Microsoft), Isabel Healthcare, Infermedica</td>
                    <td>85%</td>
                    <td class="polarity-risk">risk</td>
                </tr>
                
                <tr>
                    <td>execution_risk</td>
                    <td>competitive_threat</td>
                    <td>Microsoft Nuance has 500x resources; unclear diffe</td>
                    <td>70%</td>
                    <td class="polarity-risk">risk</td>
                </tr>
                </tbody>
            </table>
            

            <h3>Neutral Evidence</h3>
            
            <table class="evidence-table">
                <thead>
                    <tr>
                        <th>Type</th>
                        <th>Field</th>
                        <th>Value</th>
                        <th>Confidence</th>
                        <th>Polarity</th>
                    </tr>
                </thead>
                <tbody>
                <tr>
                    <td>company_identity</td>
                    <td>legal_name</td>
                    <td>HealthBridge AI Inc.</td>
                    <td>100%</td>
                    <td class="polarity-neutral">neutral</td>
                </tr>
                
                <tr>
                    <td>company_identity</td>
                    <td>founded_date</td>
                    <td>2022-03</td>
                    <td>95%</td>
                    <td class="polarity-neutral">neutral</td>
                </tr>
                
                <tr>
                    <td>round_terms</td>
                    <td>pre_money_valuation</td>
                    <td>18000000</td>
                    <td>95%</td>
                    <td class="polarity-neutral">neutral</td>
                </tr>
                
                <tr>
                    <td>round_terms</td>
                    <td>raise_amount</td>
                    <td>4000000</td>
                    <td>95%</td>
                    <td class="polarity-neutral">neutral</td>
                </tr>
                
                <tr>
                    <td>round_terms</td>
                    <td>instrument_type</td>
                    <td>Series A Preferred</td>
                    <td>95%</td>
                    <td class="polarity-neutral">neutral</td>
                </tr>
                
                <tr>
                    <td>traction</td>
                    <td>arr</td>
                    <td>180000</td>
                    <td>85%</td>
                    <td class="polarity-neutral">neutral</td>
                </tr>
                
                <tr>
                    <td>team_composition</td>
                    <td>team_size</td>
                    <td>12</td>
                    <td>90%</td>
                    <td class="polarity-neutral">neutral</td>
                </tr>
                
                <tr>
                    <td>team_composition</td>
                    <td>clinical_advisors</td>
                    <td>2</td>
                    <td>85%</td>
                    <td class="polarity-neutral">neutral</td>
                </tr>
                
                <tr>
                    <td>regulatory_risk</td>
                    <td>fda_status</td>
                    <td>Pre-submission meeting scheduled; Class II 510(k) </td>
                    <td>85%</td>
                    <td class="polarity-neutral">neutral</td>
                </tr>
                
                <tr>
                    <td>business_model</td>
                    <td>revenue_model</td>
                    <td>$500/physician/month SaaS</td>
                    <td>85%</td>
                    <td class="polarity-neutral">neutral</td>
                </tr>
                </tbody>
            </table>
            

            
        </section>
        
            
        <section id="deal-evaluation">
            <h2>4. Deal Evaluation</h2>

            <div style="background: #f5f5f5; padding: 20px; border-radius: 8px; margin-bottom: 20px;">
                <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 15px;">
                    <div>
                        <span style="color: #666; font-size: 12px;">Company</span>
                        <p style="font-weight: 600; font-size: 18px;">HealthBridge AI Inc.</p>
                    </div>
                    <div>
                        <span style="color: #666; font-size: 12px;">Company ID</span>
                        <p style="font-family: monospace;">healthbridge-2024</p>
                    </div>
                    <div>
                        <span style="color: #666; font-size: 12px;">Sector</span>
                        <p>Not specified</p>
                    </div>
                    <div>
                        <span style="color: #666; font-size: 12px;">Stage</span>
                        <p>Not specified</p>
                    </div>
                </div>
            </div>

            <h3>Category Summaries</h3>
            
                <div style="margin-bottom: 15px;">
                    <h4 style="font-size: 14px; color: #666; margin-bottom: 5px;">Traction</h4>
                    <p style="font-size: 14px; background: #f8f9fa; padding: 10px; border-radius: 4px;">
                        arr: 180000; pilot_clinics: 3; physician_nps: 72
                    </p>
                </div>
                
                <div style="margin-bottom: 15px;">
                    <h4 style="font-size: 14px; color: #666; margin-bottom: 5px;">Team</h4>
                    <p style="font-size: 14px; background: #f8f9fa; padding: 10px; border-radius: 4px;">
                        founder_background: MIT CS PhD, 8 years ML at Apple Health; team_size: 12; clinical_advisors: 2
                    </p>
                </div>
                
                <div style="margin-bottom: 15px;">
                    <h4 style="font-size: 14px; color: #666; margin-bottom: 5px;">Market</h4>
                    <p style="font-size: 14px; background: #f8f9fa; padding: 10px; border-radius: 4px;">
                        tam: 12000000000; market_timing: Post-COVID telehealth adoption accelerating AI interest
                    </p>
                </div>
                
                <div style="margin-bottom: 15px;">
                    <h4 style="font-size: 14px; color: #666; margin-bottom: 5px;">Risks</h4>
                    <p style="font-size: 14px; background: #f8f9fa; padding: 10px; border-radius: 4px;">
                        domain_expertise_gap: No full-time clinical leadership; advisors part-time; fda_status: Pre-submission meeting scheduled; Class II 510(k) pathway; clearance_timeline: 12-18 months estimated
                    </p>
                </div>
                
        </section>
        
            
        <section id="counterfactual-analysis">
            <h2>5. Counterfactual & Sensitivity Analysis</h2>

            <div class="stat-grid">
                <div class="stat-box">
                    <div class="stat-value">100%</div>
                    <div class="stat-label">Robustness Score</div>
                </div>
                <div class="stat-box">
                    <div class="stat-value">100%</div>
                    <div class="stat-label">Stability Margin</div>
                </div>
                <div class="stat-box">
                    <div class="stat-value">20</div>
                    <div class="stat-label">CFs Tested</div>
                </div>
                <div class="stat-box">
                    <div class="stat-value">0</div>
                    <div class="stat-label">Flips Found</div>
                </div>
            </div>

            <div style="background: #f5f5f5; padding: 15px; border-radius: 8px; margin: 20px 0;">
                <p style="font-size: 14px;">The decision is highly stable with a robustness score of 100%. 0 of 20 counterfactuals (0%) resulted in decision flips. The decision is robust to most reasonable changes in evidence.</p>
            </div>

            <h3>Critical Claims</h3>
            <p style="font-size: 14px; color: #666; margin-bottom: 15px;">
                Claims most likely to flip the decision if changed:
            </p>
            <p style="color: #666;">No critical claims identified.</p>

            <h3>Decision Flip Scenarios</h3>
            <p style="color: #666;">No decision flip scenarios found.</p>
        </section>
        
            
        <section id="uncertainty">
            <h2>6. Uncertainty & Limitations</h2>

            <div class="uncertainty-meter">
                <div class="uncertainty-item">
                    <div class="uncertainty-label">Epistemic Uncertainty</div>
                    <div class="uncertainty-value">20%</div>
                    <div style="font-size: 11px; color: #888;">Reducible with more data</div>
                </div>
                <div class="uncertainty-item">
                    <div class="uncertainty-label">Aleatoric Uncertainty</div>
                    <div class="uncertainty-value">15%</div>
                    <div style="font-size: 11px; color: #888;">Inherent randomness</div>
                </div>
                <div class="uncertainty-item">
                    <div class="uncertainty-label">Confidence Level</div>
                    <div class="uncertainty-value">MEDIUM</div>
                    <div style="font-size: 11px; color: #888;">Overall assessment</div>
                </div>
            </div>

            
            <div class="data-gaps">
                <h4>Data Gaps</h4>
                <ul>
                    <li>Limited evidence for team quality (only 1 claim)</li>
                </ul>
            </div>
            
            
            <div class="recommendations">
                <h4>Recommendations for Due Diligence</h4>
                <ul>
                    <li>Standard due diligence processes recommended</li>
                </ul>
            </div>
            

            <h3>Key Assumptions</h3>
            <ul style="margin-left: 20px; margin-bottom: 20px;">
                <li style="font-size: 14px; margin-bottom: 5px;">Evidence provided is accurate and current</li><li style="font-size: 14px; margin-bottom: 5px;">Market conditions remain stable during analysis period</li><li style="font-size: 14px; margin-bottom: 5px;">No material undisclosed information exists</li><li style="font-size: 14px; margin-bottom: 5px;">Historical performance is indicative of future potential</li>
            </ul>

            <h3>Limitations</h3>
            <ul style="margin-left: 20px;">
                <li style="font-size: 14px; margin-bottom: 5px;">This analysis is decision support only, not investment advice</li><li style="font-size: 14px; margin-bottom: 5px;">Confidence scores reflect model uncertainty, not success probability</li><li style="font-size: 14px; margin-bottom: 5px;">Analysis is based solely on provided evidence</li><li style="font-size: 14px; margin-bottom: 5px;">External factors not in evidence graph are not considered</li>
            </ul>
        </section>
        
            
        <section id="audit-metadata">
            <h2>7. Audit Metadata</h2>

            <div class="metadata-grid">
                <div class="metadata-item">
                    <span class="metadata-label">Report ID:</span>
                    <span class="metadata-value" style="font-family: monospace;">report_ff4e526bbf9b</span>
                </div>
                <div class="metadata-item">
                    <span class="metadata-label">Generated At:</span>
                    <span class="metadata-value">2026-01-12 20:23:54 UTC</span>
                </div>
                <div class="metadata-item">
                    <span class="metadata-label">Model Version:</span>
                    <span class="metadata-value">1.0.0</span>
                </div>
                <div class="metadata-item">
                    <span class="metadata-label">Trace ID:</span>
                    <span class="metadata-value" style="font-family: monospace;">N/A</span>
                </div>
                <div class="metadata-item">
                    <span class="metadata-label">Analyst ID:</span>
                    <span class="metadata-value">N/A</span>
                </div>
                <div class="metadata-item">
                    <span class="metadata-label">Claims Analyzed:</span>
                    <span class="metadata-value">31</span>
                </div>
                <div class="metadata-item">
                    <span class="metadata-label">Counterfactuals Tested:</span>
                    <span class="metadata-value">20</span>
                </div>
                <div class="metadata-item">
                    <span class="metadata-label">Reproducibility Seed:</span>
                    <span class="metadata-value">42</span>
                </div>
            </div>
        </section>
        
        </main>

        <footer class="report-footer">
            <div class="disclaimer">
                <strong>DISCLAIMER:</strong> This report is decision support only, not investment advice.
                All investment decisions remain the sole responsibility of the investment committee.
                Confidence scores reflect model uncertainty, not probability of investment success.
            </div>
            <div class="footer-meta">
                JURIS-AGI VC Decision Intelligence | Model Version: 1.0.0
            </div>
        </footer>
    </div>
</body>
</html>